Differential Inhibition of TRAIL-Mediated DR5-DISC Formation by Decoy Receptors 1 and 2

Molecular and Cellular Biology - United States
doi 10.1128/mcb.00520-06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Notch Inhibition Restores TRAIL-mediated Apoptosis via AP1-dependent Upregulation of DR4 and DR5 TRAIL Receptors in MDA-MB-231 Breast Cancer Cells

International Journal of Oncology
Cancer ResearchOncology
2013English

FTY720 Enhances TRAIL-mediated Apoptosis by Up-Regulating DR5 and Down-Regulating McL-1 in Cancer Cells

Oncotarget
Oncology
2015English

Lipocalin 2 Inversely Regulates TRAIL Sensitivity Through P38 MAPK-mediated DR5 Regulation in Colorectal Cancer

International Journal of Oncology
Cancer ResearchOncology
2018English

[Corrigendum] Lipocalin�2 Inversely Regulates TRAIL Sensitivity Through P38 MAPK‑mediated DR5 Regulation in Colorectal Cancer

International Journal of Oncology
Cancer ResearchOncology
2019English

TRAIL, DR5 and Caspase 3-Dependent Apoptosis in Vessels of Diseased Human Temporomandibular Joint Disc. An Immunohistochemical Study

European Journal of Histochemistry
MedicineCell BiologyHistologyBiophysics
2010English

Role of Endoplasmic Reticulum Stress in Α-Tea Mediated TRAIL/DR5 Death Receptor Dependent Apoptosis

PLoS ONE
Multidisciplinary
2010English

TRAIL-Mediated Apoptosis in HIV-1-Infected Macrophages Is Dependent on the Inhibition of Akt-1 Phosphorylation

Journal of Immunology
AllergyImmunology
2006English

Phytosphingosine in Combination With TRAIL Sensitizes Cancer Cells to TRAIL Through Synergistic Up-Regulation of DR4 and DR5

Oncology Reports
MedicineCancer ResearchOncology
2007English

Ca2+-Calmodulin Inhibits Ca2+ Release Mediated by Type-1, -2 and -3 Inositol Trisphosphate Receptors

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
2000English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy